Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier BV in Annals Of Oncology
- Vol. 32 (1), 113-119
- https://doi.org/10.1016/j.annonc.2020.10.473
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi ArabiaEmerging Infectious Diseases, 2019
- Vaccination coverage in healthcare workers: a multicenter cross-sectional study in Italy.2019
- Infections in Cancer Patients with Solid Tumors: A ReviewInfectious Diseases and Therapy, 2017
- Transmission of MERS-Coronavirus in Household ContactsNew England Journal of Medicine, 2014
- Serological assays for emerging coronaviruses: Challenges and pitfallsVirus Research, 2014
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancerCell Death & Differentiation, 2013
- Prolonged persistence of measles virus RNA is characteristic of primary infection dynamicsProceedings of the National Academy of Sciences of the United States of America, 2012
- Nosocomial infections in patients with cancerThe Lancet Oncology, 2009
- Disappearance of Antibodies to SARS-Associated Coronavirus after RecoveryNew England Journal of Medicine, 2007
- Profile of Specific Antibodies to the SARS-Associated CoronavirusNew England Journal of Medicine, 2003